TickerTalks
Browse all tickers →
TickerTalks›$MET
MEMET

MetLife, Inc.

$MET·$63B·Insurance - Life·Financial Services
$97.47+0.8%YTD+21.8%1Y+26.0%
Mentions · last 7 days
2026-08-06: 65 posts2026-08-07: 46 posts2026-08-08: 75 posts2026-08-09: 23 posts2026-08-10: 31 posts2026-08-11: 32 posts2026-08-12: 37 posts311-9%
Price updated 13h ago·X counts updated 2d ago
MEMET
$METMetLife, Inc.
$97.47+0.84%311 posts-9%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Top X posts

Today's AI verdict on what's driving $MET, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Proven numbersAcceleratingAI verdict · as of 2026-08-13

The move is getting stronger, with heavier trading behind it.

Boring insurance compounder at 87% of 52w range — 30% FCF yield and $3B buyback are the whole story.

MetLife is one of the largest US-based global insurance companies, operating across life insurance, annuities, employee benefits, and asset management. The stock is up 26% over 12 months as the operating results keep beating and the $3B buyback authorization anchors the return-of-capital thesis.

  • The Q2 print keeps the compounder story intact: EPS $2.43 beat $2.30, the last four EPS surprises were +6%, +7%, +14%, and beat — analysts model FY26 EPS at $9.85 climbing to $12.27 by FY28, which supports the 16.6x trailing P/E and the recently-announced $3B buyback.
  • Free cash flow generation is the moat: 29.9% FCF yield is one of the highest in the S&P 500, reflecting the insurance-float-plus-net-investment-income model — and the pet-insurance / VetDogs partnership is a small strategic add that extends the brand across new benefits categories.
  • The dilution and structural governance signal is worth naming: MetLife Policyholder Trust filed an SC 13D/A confirming beneficial ownership of 102M shares (16.1%) as of July 31 — this is an administrative update from the 1999 Plan of Reorganization, not a change, but it's the kind of structural detail that reminds investors the equity comes with a policyholder-trust overhang layer.

The November 4 Q3 print is the next gate — a continued NII beat plus additional buyback execution progress toward the $3B target is what extends the accelerating tape above $102. A specific Asia-Pacific insurance revenue miss, a fresh long-yield reversal, or a credit-cycle turn hitting the fixed-income portfolio is what would take a name at 87% of the 52-week range off the highs first.

What to watch: November 4 Q3 print — a continued NII beat plus additional buyback execution progress toward the $3B target extends the accelerating tape above $102; an Asia-Pacific insurance revenue miss, a long-yield reversal, or a credit-cycle turn hitting the fixed-income portfolio takes it off the highs.

On the calendar: 2026-11-04 — Q3 earnings

cashtag hijacked

X sentiment

What the X crowd is saying right now — descriptive, summarised from the day’s posts.

Bullish sentiment35 posts analyzed · as of 2026-08-13

Discussion centers on Meteora's LP Stimulus Season 2, with 6M MET (0.6% of supply, ~$900k-$1M) allocated to expert contributors and public submissions open August 10-24. Users describe MET accumulating with rising buy-side volume and bullish setups, and it appears repeatedly in Solana-ecosystem bull-cycle bags alongside JUP, JTO, and PUMP. Traders frame Meteora as the liquidity layer of Solana and a higher-beta alt-to-alt.

Read the AI verdict + X sentiment for $MET

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Global insurer and financial services firm offering life, dental, and disability insurance, annuities, and employee benefits across five regional segments.

Industry overviewAI analysisGenerated by AI from underlying data

Where Insurance - Life sits in its cycle right now — and what that implies for $MET.

Insurance - Life · Financial Services

No material change from last week — higher portfolio yields improve new-business economics for life insurers as the rate cycle stabilizes, funding capital return programs and reducing rate-driven spread compression.

What this means for $MET

Partial — Global insurer and financial services firm offering life, dental, and disability insurance, annuities, and employee benefits across five regional segments; partial earnings exposure to insurance - life demand dynamics through its product portfolio.

Top industry ETF

$KIESPDR S&P Insurance ETF
+7.7%YTD
+8.8%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
16.6How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
0.5%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
6.3%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
29.9%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
0.7Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
12.9%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
28.4%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.7Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Aug 5, 2026$2.43$2.30+5.7%
Q1 2026May 6, 2026$2.42$2.27+6.6%
Q4 2025Feb 4, 2026$2.58$2.34+10.3%
Q3 2025Nov 5, 2025$2.34$2.31+1.3%
Next earningsWed, Nov 4·consensus EPS $2.55

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$19.1B+4.4%37.2%7.9%$1.75$2.7B
Q4 FY25$23.8B+29.1%30.5%4.7%$1.17$8.1B
Q3 FY25$16.9B-7.7%17.4%7.2%$1.23$3.6B
Q2 FY25$17.2B-1.8%26.4%5.7%$1.04$2.2B

Forward consensus

4-year forecast · up to 7 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$80.3B$79.2B – $81.4B$9.85$9.67 – $10.217
FY27$84.1B$82.6B – $85.6B$10.97$10.74 – $11.547
FY28$88.3B$86.2B – $89.8B$12.27$10.29 – $13.807
FY29$92.9B$91.1B – $94.4B$13.00$12.67 – $13.283

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.5×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.90%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+7.1%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+21.0%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatHigh float · 537.5M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.4% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.765-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

No open-market buys or sells in the last 180 days.

+ 48 other (41 awards · 7 inkinds) in window

See when $MET insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

SC 13D/AActivist amendmentAug 6SC 13D/A
AI summary

MetLife, Inc.'s Board of Directors filed Amendment No. 106 to a Schedule 13D on August 6, 2026, reporting beneficial ownership of 102,098,469 shares of MetLife common stock (approximately 16.1%) held in the MetLife Policyholder Trust as of July 31, 2026. The trust was created under MetLife's 1999 Plan of Reorganization, when 494,466,664 shares were originally distributed; the decline to 102,098,469 reflects policyholder redemptions, the 2008 Reinsurance Group of America split-off, withdrawals, and escheatment over 26 years. This is a routine administrative update to the Board's structural 13D position — no activist intent, no proposed transaction, and no change in ownership strategy.

8-KPress release / Reg FDAug 58-K — Item 2.02: Earnings release · Item 7.01: Press release / Reg FD · Item 8.01: Other event
AI summary

MetLife, Inc. filed its Q2 2026 earnings 8-K on August 5, 2026, reporting financial results for the quarter ended June 30, 2026. MetLife has common stock (MET) and three preferred series (Series A floating rate, Series E 5.625%, Series F) listed on NYSE. The filing also includes Reg FD (Item 7.01) and Item 8.01 disclosures, likely an investor presentation and supplemental financial data. No headline figures appear in the excerpt; the actual results are in the attached exhibits. This is a routine but market-relevant quarterly earnings disclosure for one of the largest U.S. life insurance companies.

8-KPress release / Reg FDJun 298-K — Item 7.01: Press release / Reg FD
AI summary

MetLife disclosed preliminary Q2 2026 variable investment income of $220M-$270M pre-tax versus full-year 2026 guidance of approximately $1.6B pre-tax, including private equity, real estate funds, and prepayment fees. Q2 tracking below pro-rata pace of guidance; suggests a softer quarter on alternative investments.

8-KShareholder voteJun 228-K — Item 5.07: Shareholder vote
SC 13D/AActivist amendmentMay 7SC 13D/A
AI summary

Monica M. Curtis (MetLife, Inc., 200 Park Avenue, New York) filed an amended Schedule 13D for MetLife with event date May 7, 2026. Specific ownership details are not visible in the excerpt. Amendment to an institutional insider position in MetLife.

8-KPress release / Reg FDMay 68-K — Item 2.02: Earnings release · Item 7.01: Press release / Reg FD · Item 8.01: Other event
AI summary

MetLife issued Q1 2026 financial results (quarter ended March 31, 2026): Earnings Release (Exhibit 99.1), Quarterly Financial Supplement (Exhibit 99.2), and Total AUM Fact Sheet (Exhibit 99.3). Comprehensive quarterly earnings and AUM disclosure.

8-KPress release / Reg FDApr 78-K — Item 7.01: Press release / Reg FD
3/ANew insider — initial holdingsMar 193/A
+ 18 other (3 routine 8-Ks · 2 10-Qs · 2 13Gs · 2 proxys) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

MetLife Pet Insurance and America's VetDogs Partner to Help Co-Raise Future Service Dog for Veteran or First Responder with Disabilitiesgurufocus.com·3d agoMetLife Pet Insurance and America's VetDogs Partner to Help Co-Raise Future Service Dog for Veteran or First Responder with Disabilitiesbusinesswire.com·3d agoMetLife Q2 Earnings Call Highlightsmarketbeat.com·6d agoMetLife Tops Q2 Earnings Estimates on Strong Investment Incomezacks.com·8d agoMetLife, Inc. (MET) Q2 2026 Earnings Call Transcriptseekingalpha.com·8d ago

More in Insurance - Life

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$GWLPF
Voices on X · top 15 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport